Agilon, Baby Boy .
HRN: 24-76-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/17/2024
04/24/2024
IV
13.5mg
Q12H
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes